Levonorgestrel-releasing (20mcg/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives [3] (multiple letters)

British Journal of Obstetrics and Gynaecology

Volumn 108, Issue 7, 2001, Pages 770-771

  Onyeka, B A ^a  

^a BLACKPOOL TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

AMENORRHEA; CHRONOTHERAPY; CLINICAL TRIAL; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG TOLERABILITY; ENDOCRINE DISEASE; FEMININITY; HUMAN; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; LETTER; MENOPAUSE; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; META ANALYSIS; PATIENT SATISFACTION; PREGNANCY; PRIORITY JOURNAL;

EID: 0034883747     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-5456(00)00157-1     Document Type: Letter

References (3)

1. R.S. French F.M. Cowan D. Maansour Levonorgestrel-releasing (20ug/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives Br J Obstet Gynaecol 107 2000 1218 1225
2. C.G. Nilsson H. Allonen J. Diaz T. Luukkainen Two years experience with Levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomised comparative performance study Fertil Steril 39 1983 187 192
3. I. Sivin J. Stern Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380 Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraceptive Research (ICCR) Fertil Steril 61 1994 70 77